The Parenteral Drug Association (PDA) is a leading global provider of science, technology and regulatory information and education for the pharmaceutical and biopharmaceutical community.
SeerPharma Senior GMP Consultant Michelle Peake has been invited to speak at PDA Annex 1 Implementation: Inspection Ready Workshop 2025, 17 - 18 June 2025 in ...
By 2030, it is projected that over 60% of the global population will reside in the Asia-Pacific region, with one in four individuals aged 60 or older1. This demographic shift, coupled with rising healthcare costs, an increase in chronic diseases, and a more discerning healthcare consumer base, is driving exceptional growth in the region’s...
For over 35 years, SeerPharma has served as a trusted partner to life science organisations across the Asia-Pacific (APAC) region, supporting them in navigating complex challenges related to Quality Assurance and GxP compliance.
With the mainstream support for SAP ECC6 ending in 2027 and extended maintenance available only until 2030 at an additional cost, Pharmaceutical and Medical Device manufacturers are facing a critical decision: how to upgrade their ERP systems in a way that meets both business goals and regulatory obligations. The move to SAP S/4HANA presents a...
SeerPharma is pleased to announce that Ian Lucas, Director and Training Manager, will be presenting at the ARCS Annual Conference 2025, to be held from 3–5 June at the International Convention Centre (ICC) in Darling Harbour, Sydney.
SeerPharma is proud to announce that one of its very own, Consultant and Lecturer Aaron Bennett, has been selected to participate in the 2025 Merck Innovation Cup as part of the Smart Manufacturing team. The event will be held at Merck’s global headquarters in Darmstadt, Germany, from 19 to 25 July.
The 2022 revision of the PIC/S Guide to GMP for Medicinal Products (PE 009-17) Annex 1 is expected to be adopted by the Therapeutic Goods Administration (TGA) in 2025 and Contamination Control Strategy (CCS) has emerged as a key new requirement. While CCS under Annex 1 is central for sterile drug manufacturers, it is also applicable for...
Artificial Intelligence is reshaping industries at a rapid pace—and life sciences is no exception. While excitement about AI’s potential is high, many quality and manufacturing teams remain in the early stages of implementation. In this webinar, discover how MasterControl is closing this gap with innovative, purpose-built AI solutions that elevate...
Audit trails play a crucial role in ensuring data integrity, traceability and compliance with Good Manufacturing Practice (GMP) regulations. Under the PIC/S Guide to Good Manufacturing Practice for Medicinal Products (PE 009-16), Annex 11 outlines specific requirements for computerised systems, emphasising the need for audit trail reviews....
As a quality manager for a life sciences company, you face unique challenges in maintaining high quality standards while planning for growth - often with limited resources and budget constraints. Choosing the right quality management system (QMS) is critical, but how do you balance compliance, efficiency, scalability and value without making...
Copyright © SeerPharma
